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Objective. To evaluate if early cholecystectomy (EC) is the most appropriate treatment for acute cholecystitis compared to delayed
cholecystectomy (DC). Patients and Methods. A retrospective cohort study of 1043 patients was carried out, with a group of 531 EC
cases and a group of 512 DC patients. The following parameters were recorded: (1) postoperative hospital morbidity, (2) hospital
mortality, (3) days of hospital stay, (4) readmissions, (5) admission to the Intensive Care Unit (ICU), (6) type of surgery, (7)
operating time, and (8) reoperations. In addition, we estimated the direct cost savings of implementing an EC program. Results.
The overall morbidity of the EC group (29.9%) was significantly lower than the DC group (38.7%). EC demonstrated significantly
better results than DC in days of hospital stay (8.9 versus 15.8 days), readmission percentage (6.8% versus 21.9%), and percentage
of ICU admission (2.3% versus 7.8%), which can result in reducing the direct costs. The patients who benefited most from an EC
were those with a Charlson index > 3. Conclusions. EC is safe in patients with acute cholecystitis and could lead to a reduction in
the direct costs of treatment.
1. Introduction
Acute cholecystitis is a pathology of inflammatory origin,
usually associated with cholelithiasis, with a high incidence
in our environment. The treatment of acute cholecystitis
involves an important socioeconomic impact. There are two
surgical therapeutic options: early cholecystectomy (EC)
during the same admission or delayed cholecystectomy (DC)
during a later admission after conservative treatment.
The first studies that assessed EC as a treatment for
acute cholecystitis date back to the 1950s [1–3]. In 1970, the
first controlled study was published by van der Linden and
Sunzel, demonstrating better morbidity and shorter average
hospital stay after open EC [4].The exponential development
of laparoscopic surgery occurred during the 1990s. Some
of the first publications about laparoscopic EC showed bad
results in terms of morbimortality and high percentages of
bile duct injuries. Based on these results, laparoscopic ECwas
deprecated and even considered a contraindication for the
treatment of acute cholecystitis, favoring initial conservative
treatment followed by a laparoscopic DC. In 1998, Kiviluoto
et al. reported similar results in terms of morbimortality
between laparoscopic EC and open EC [5]. In that same
year, Lo et al. presented the first controlled study that
compared laparoscopic EC and laparoscopic DC, with lower
morbidity and hospital stay in the laparoscopic EC group
[6]. Recently, many studies have reported similar results in
favor of laparoscopic EC. It is important to note that the
vast majority of these articles only include laparoscopic cases,
which could cause a bias in the external validity of these
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studies, as they exclude many of the less favorable cases
involving open EC [7–17].
In spite of many publications that suggest benefits in
favor of EC, there is still controversy regarding the tim-
ing to perform cholecystectomy. Although literature favors
laparoscopic EC, most evidence comes from prospective
studies specifically designed to prove this particular aspect
[6–11], which probably does not reflect the worldwide clinical
practice. In addition, it is well known that laparoscopic EC is
not the usual practice in many hospitals [12, 17–23].
Our study aims to compare two treatment protocols for
acute cholecystitis, in two similar hospital centers covering
two health areas with similar characteristics and with compa-
rable morbimortality results in laparoscopic cholecystectomy
for symptomatic cholelithiasis: (A) EC, performed within 48
hours after admission, versus (B) DC, performed 2–4months
after the index episode.
2. Patients and Methods
2.1. Study Population. This is a cohort retrospective study that
includes 1043 patients, consecutively treated between January
1, 2005, and December 31, 2010, for acute cholecystitis. The
diagnosis was made according to the Tokyo 2013 criteria
[24]. The cases of cholecystitis associated with pancreatitis,
choledocholithiasis, or cholangitis and those treated with
percutaneous cholecystostomy were excluded. In addition, 16
cases from EC group who were treated as DC and 10 cases
from DC group who were treated as EC were also excluded
due to protocol violation.
The EC group consisted of 531 patients (50.9%), treated
at the University Hospital “Marqués de Valdecilla”, in San-
tander. This group was treated with early cholecystectomy,
performed within 48 hours after admission to the Surgery
Department. 473 patients (89.1%) were operated on within 72
hours of symptoms onset (<72 h) and 54 patients (10.2%) after
72 hours (>72 h). Four patients (0.7%) died before surgery,
because of severe cholecystitis and comorbidity.
The DC group consisted of 512 patients (49.1%), treated
at the Burgos University Hospital. This group was treated
with delayed cholecystectomy, performed 2–4 months after
the index episode. A total of 268 patients (52.4%) underwent
elective surgery after an average of 105 days, 143 patients
(27.9%) required surgery ahead of schedule (urgent surgery),
and 101 patients (19.7%) received no intervention.
2.2. Study Variables. There are (1) postoperative hospital
morbidity: overall morbidity (medical and surgical compli-
cations), surgical morbidity, and the most relevant surgical
complications (bleeding, infection, and bile duct injury,
according to the Strasberg classification [25]), (the severity of
complications was stratified according to the Clavien-Dindo
scale [26]), (2) hospital mortality, (3) days of hospital stay,
(4) readmissions (note that admission for elective cholecys-
tectomy within the DC group is not regarded as reentry),
(5) admissions to the Intensive Care Unit (ICU), (6) type of
surgery, (7) operating time, and (8) reoperations.
Additionally, the direct cost savings by implementation of
an EC program were estimated.
2.3. Statistical Analysis. Frequency distributions and sum-
mary statistics were calculated for all variables; values are
expressed as mean or median and range. A Kolmogorov-
Smirnov test was used to study the distribution of each
variable, and P-P andQ-Q charts were used to confirm it.The
majority of variables did follow a normal distribution, and
parametric tests were used for comparisons.The independent
variable of interest was the variable EC versus DC. The
endpoints of this study were the evaluation of morbidity,
mortality, days of hospital stay, readmissions, admissions
to ICU, type of surgery, operating time, and reoperations.
Univariate analysis was performed with logistic or linear
regression models or a Mantel-Haenszel chi-square test. A
multivariate analysis was performed in order to analyze
if the following variables were confounders between the
independent and endpoints variables: age, sex, ASA degree
[27], Charlson index [28], and severity of the cholecystitis.
A significance level of 5% (𝑝 < 0.05) was accepted in all
cases. SPSS software version 19.0 (SPSS, IBMCorp., Armonk,
NY) was used for the statistical analysis. Additionally ROC
analyses of the risk of death, the risk of complications, and
the risk of reoperation are included; the area under the ROC
curve shows the ability of any statistical model to predict an
event. The closer it gets to 1, the greater its predictive ability
will be and thus its reliability.
3. Results
3.1. Comparison of the Groups. The EC and DC groups were
compared on the basis of age, sex, medical-surgical risk
(ASA), Charlson index, percentage of diabetic patients, and
severity of the acute cholecystitis according to the Tokyo 2013
consensus criteria [24]. The EC group had a significantly
lower average age, which made the average score for the
Charlson index also significantly lower in this group, due to
its direct relation with age and comorbidity. Similar results
were found for comorbidity (ASA) and severity of acute
cholecystitis (Table 1).
3.2. Overall Morbidity. The morbidity in the EC group was
lower than in the DC group, with statistically significant
differences. Within the EC group, there were no significant
differences between the morbidity of patients <72 h and the
morbidity of patients >72 h. Of particular note among the
DC patients was the low morbidity of patients operated on
electively and the high morbidity of patients operated on
urgently (Table 2).
Table 3 shows the overall postoperative complications
according to the Clavien-Dindo scale, considering mild
complications as grades I and II and severe complications as
grades III and IV. In the multivariate analysis, we found that
EC had a 39% lower risk of complications than DC (OR =
0.61; 95% CI 0.45–0.82; 𝑝 < 0.05) and that the risk of
complications increases at a rate of 17% for each point of the
Charlson index (OR = 1.17; 95% CI 1.01–1.36; 𝑝 < 0.05) and
proportionally with the severity of the cholecystitis: moderate
cholecystitis (OR = 2.34; 95% CI 1,70–3,23, 𝑝 < 0.05) and
severe cholecystitis (OR = 7.70; 95% CI 4.21–14.07; 𝑝 < 0.05).
The area under the ROC curve is 0.73, which indicates that
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Female∗, 𝑛 (%) 326 (42.6) 206 (40.2)
ASA∗, 𝑛 (%)
I 115 (21.6) 120 (23.4)
II 259 (48.8) 242 (47.3)
III 139 (26.2) 129 (25.2)
IV 18 (3.4) 21 (4.1)
Charlson 3.7 4.1
Diabetics∗, 𝑛 (%) 113 (22.1) 87 (17.0)
Severity of cholecystitis∗, 𝑛 (%)
Mild 229 (43.1) 234 (45.7)
Moderate 262 (49.4) 235 (46.1)
Severe 40 (7.5) 42 (8.2)
∗
𝑝 > 0.05.





EC 29.9% (158) 17.6% (93) 0.8% (6)
<72 h 29.6% (140) 16.9% (80) 0.4% (2)
>72 h 33.3% (18) 24.1% (13) 0%
No surgery 100% (4)
DC 38.7% (157) 29.9% (123) 2.7% (14)
Elective 22.4% (60) 18.3% (49) 0.4% (1)
Urgent 69.2% (97) 51.7% (74) 2.8% (4)
No surgery 8.9% (9)
Highlighted in bold font are statistically significant values.
Table 3: Overall complications according to the Clavien-Dindo
scale.
I-II III-IV
EC 20.4% (108) 9.3% (49)
<72 h 20.1% (95) 9.3% (44)
>72 h 24.1% (13) 9.3% (5)
DC 29.7% (122) 8.3% (34)
Elective 19.0% (51) 3.0% (8)
Urgent 49.7% (71) 18.2% (26)
Highlighted in bold font are statistically significant values.
the predictive ability of the model to foresee complications is
not very high.
An analysis of the morbidity in terms of the Charlson
index, using univariate logistic regression, was made. We
observed that EC patients with Charlson index < 3 had
complications in 17.6% (35/199) of cases, while DC patients
with Charlson index < 3 had complications in 21.6% (32/148)
of cases, (OR= 1.29;𝑝 > 0.05).On the other hand, ECpatients
Table 4: Surgical complications according to the Clavien-Dindo
scale.
I-II III-IV
EC 10.3% (54) 7.2% (37)
<72 h 9.5% (45) 7.2% (34)
>72 h 16.7% (9) 7.4% (4)
DC 23.1% (95) 6.6% (27)
Elective 15.3% (41) 3.0% (8)
Urgent 37.8% (54) 13.3% (19)
Highlighted in bold font are statistically significant values.




EC 9.7% (51) 3.0% (16) 2.8% (15) 0.6% (3)
<72 h 9.3% (44) 2.5% (12) 2.7% (13) 0.6% (3)
>72 h 12.9% (7) 7.4% (4) 3.7% (2) 0%
DC 16.5% (68) 1.2% (5) 4.6% (19) 1.0% (4)
Elect. 9.3% (25) 0.7% (2) 2.2% (6) 0.8% (2)
Urg. 30.1% (43) 2.1% (3) 9.1% (13) 1.4% (2)
Highlighted in bold font are statistically significant values.
with Charlson index > 3 had a 37.5% (123/328) complications
rate and DC patients with Charlson index > 3 had a 47.9%
(123/257) complications rate (OR = 1.51; 95% CI 1.32–1.89;
𝑝 < 0.05).
3.3. Surgical Morbidity. When we analyzed only surgical
complications after surgery, we observed a lower rate of
complications, statistically significant, in the EC group as
compared to the DC group. Within the EC group, there were
no significant differences between the surgical complications
of patients <72 h and the patients >72 h. In the DC group,
those operated on electively did not have such low morbidity
as would be expected, and of particular note is the high
morbidity of the urgent surgery group (Table 2).
Table 4 shows the surgical complications according to the
Clavien-Dindo scale, considering mild complications as of
grades I and II and severe complications as of grades III and
IV.
3.4. Most Relevant Surgical Complications (Table 5)
(1) Surgical Site Infection. The proportion of infections
was significantly higher in the DC group. We found
the risk of postoperative infection to be twice as high
in the DC group as the EC group (OR = 1.98; 95% CI
1.78–2.17; 𝑝 < 0.05).
(2) Bleeding. There were no significant differences in the
frequency of postoperative bleeding.
(3) Bile Duct Injury. Both the bile leakage and, more
specifically, major injuries of the bile duct (Strasberg
D-E) had a greater tendency to occur in theDCgroup,
but the differences were not statistically significant.
4 HPB Surgery
Table 6: Other results: days of hospital stay, readmissions, ICU stay, type of surgery, operating time, and reoperations.
Hosp. stay Readmiss. ICU LPS/CONV Oper. time Reoperat.
EC 8.9 (ds 7.6) 6.8% (36) 2.3% (12) 74.8%/21.6% 90.8 (ds 34.1) 4.6% (24)
<72 h 8.1 (ds 7.6) 2.1% (10) 75.1%/20.6% 91.1 (ds 38.6) 4.4% (21)
>72 h 15.5 (ds 7.8) 3.7% (2) 72.2%/30.8% 93.5 (ds 25.2) 5.6% (3)
DC 15.8 (ds 12.2) 21.9% (112) 7.8% (32) 67.9%/9.3% 89.5 (ds 28.1) 2.4% (10)
Elect. 13.6 (ds 11.9) 0% 91.4%/6.1% 84.2 (ds 18.9) 1.1% (3)
Urg. 19.9 (ds 12.2) 21.7% (31) 23.8%/32.3% 97.0 (ds 22.9) 4.9% (7)
No Surg. 15.8 (ds 12.2) 1% (1)
Highlighted in bold font are statistically significant values.
3.5. Mortality. In the DC group we found a higher mortality
than in the EC group, but the differences were not statistically
significant. Of particular note within the DC group was the
low mortality of the elective surgery, the high mortality of
the patients undergoing urgent surgery, and the very high
mortality rate of patients who did not undergo surgery
(Table 2).
It is remarkable that, in the DC group, 47 of the 92
patients (51.1%) who did not undergo surgery and did not die
in hospital during the treatment died within the next three
years.
The multivariate analysis showed that the risk of death
was lower in the EC group (OR = 0.71), but without statistical
significance (𝑝 > 0.05). We also found that the risk of
death in both groups increased by 13% for each year of age
(OR = 1.13; 95% CI 1.05–1.22; 𝑝 < 0.05) and increased
by 42% for each point in the Charlson index (OR = 1.42;
95% CI 1.01–1.98; 𝑝 < 0.05). In relation to the severity of
the cholecystitis, we found a slight increase in the risk of
death in the moderate cholecystitis patients (OR = 1.52), but
without statistical significance (𝑝 > 0.05). For its part, severe
cholecystitis was associated with a high mortality (OR = 11.8;
95% CI 2.67–52.27; 𝑝 < 0.05). The area under the ROC curve
is 0.94, which confirms that the model has a very high ability
to predict the risk of death.
3.6. Days of Hospital Stay. The average hospital stay in the EC
group was significantly lower than in the DC group (Table 6).
3.7. Readmissions. For the analysis of hospital readmissions,
we established a differentiation between admissions before
cholecystectomy and readmissions after surgery. If we analyze
all the cases as a whole, the EC group had a 6.8% readmission
rate (𝑛 = 36) (all postsurgical) and the DC group a 21.9%
readmissions rate (𝑛 = 112) (𝑝 < 0.05) (Table 6). Within
the DC group, 18.2% of the patients required at least one
readmission before surgery (𝑛 = 93). The percentage of
readmissions after surgery in DC group was 4.6% (𝑛 = 19),
which is not significantly lower than that of the EC group.
3.8. Admission to the Intensive Care Unit. We found that the
percentage of EC patients that required admission to the ICU
was significantly lower than theDC group. A high proportion
of patients who underwent urgent surgery within the DC
group required admission to the ICU (Table 6).
3.9. Type of Surgery. There were a greater percentage of
conversions from laparoscopic to open surgery in the EC
group than in the DC group (𝑝 < 0.05) (Table 6). On the
other hand, there was no significant difference between the
percentage of surgeries that were completed by laparoscopy
in the EC group (58.6%) and in the DC group (61.6%).
When we matched the type of surgical approach with
the severity of the acute cholecystitis, we found that in
the EC group, of the 394 patients (74.7%) who underwent
laparoscopic surgery, 190 patients had mild cholecystitis
(48.2%), 185 patients hadmoderate cholecystitis (46.9%), and
19 patients had severe cholecystitis (4.8%). For their part, of
the 133 patients who underwent laparotomy (25.2%), 37 had
mild cholecystitis (27.8%), 76 were admitted with moderate
cholecystitis (57.1%), and 20 suffered severe cholecystitis
(15.0%). In theDC group, of the 279 patients (67.9%) operated
on by laparoscopy, 160 had mild cholecystitis (57.3%), 116
had moderate cholecystitis (41.6%), and 3 were admitted
with severe cholecystitis (1.1%). When we looked at the
132 patients who underwent laparotomy (32.1%), we found
that 17 were admitted with mild cholecystitis (12.9%), 80
with moderate cholecystitis (60.6%), and 35 with severe
cholecystitis (26.5%). In both EC and DC, there was a
significantly higher proportion of moderate and severe cases
of acute cholecystitis in patientswhounderwent open surgery
than in those with a laparoscopic approach.
The risk of bile duct injury in relation to the surgical
approach was calculated. In the EC group, we found 9 cases
of bile duct injury in open surgery (6.8%) and 6 cases in the
laparoscopic approach (1.52%), (𝑝 < 0.05). In the DC group,
there was a higher tendency towards bile duct injury in open
surgery (7.58%) than in laparoscopic surgery (3.22%), but the
differences were not statistically significant.
3.10. Operating Time. Therewere no significant differences in
operating time between the EC and DC groups (Table 6).The
only factor that influenced the surgical time was the severity
of the cholecystitis, with a significant increase in the time for
moderate and severe cholecystitis cases (𝑝 < 0.05).
3.11. Reoperations. There were no significant differences
between the percentage of reoperations in the EC group
and the DC group (Table 6). In the multivariate analysis, it
was noted that the EC group had almost twice the risk of
reoperation of the DC group (OR = 1.90), but this ratio was
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not statistically significant (𝑝 > 0.05). It also highlighted that
severe cholecystitis had a greater risk of reoperation (OR =
2.72), but it was not statistically significant (𝑝 > 0.05). The
model has a low capacity to predict the risk of reoperation,
with area under the ROC curve of 0.66.
3.12. Estimated Direct Cost Savings. Faced with the impos-
sibility of assessing, using the data collected in the present
study, the exact difference in costs between the treatment
options of EC and DC, we instead made an approximation
of the same, taking into account the three most important
parameters with statistically significant differences between
the two study groups: Emergency Department care for
readmission, days of stay in ICU, and days of hospital stay.
The EC group had a total of 36 readmissions (0.068
readmissions per patient). The DC group had a total of
112 readmissions (0.219 readmissions per patient). If we
subtract both figures we get 0.151, which is the difference in
readmissions per patient between EC and DC.
The EC group had a total of 79 days of stay in the ICU
(0.149 days of stay in ICU per patient). The DC group had a
total of 372 days of stay in ICU (0.727 days of stay in ICU per
patient). If we subtract both figures we get 0.578, which is the
difference in days of stay in ICU per patient between EC and
DC.
The EC group had an average of 8.9 days of hospital stay
per patient and the DC group an average of 15.8 days of
hospital stay per patient. If we subtract both figures we get
6.9, which is the difference in days of hospital stay per patient
between EC and DC.
Therefore, each patient treated with EC would save 0.151
readmissions, 0.578 days of stay in ICU, and 8.9 days of
hospitalization.
4. Discussion
In this comprehensive retrospective study, we compared,
from a clinical point of view and in relation to the two
possible surgical option treatments in the management of
acute cholecystitis, the result of the treatment protocols for
acute cholecystitis of two nearby hospitals, with very similar
profiles in terms of capacity and organizational structure.
Both hospitals provide health care to populationswith similar
demographic characteristics. We have contrasted the reality
of the daily practice in the treatment of acute cholecystitis,
without a selection of patients according to age, comorbid-
ity, the severity of the acute cholecystitis or the surgical
approach. In this way, our study has also included patients
who underwent open surgery that had a greater proportion
of cases of moderate and severe cholecystitis, factors that
most influence, according to our data, the appearance of
complications and mortality. This fact means that studies,
which only include laparoscopic surgery cases, may have
questionable external validity, due to dismissal of cases that
have potentially worse evolution.
Of note, in the DC group, patients were operated on after
an average of 105 days, an interval which is longer than the
ideal 6–8-week period. This was due to the waiting list of
a public hospital. We do not think that this influenced the
morbidity rate, since fibrosis tends to decrease after several
months.
Data from our study in relation to morbidity indicate
that DC had a higher rate of complications than EC, due to
a higher proportion of minor surgical complications. Many
of the previously published studies also showed higher rates
of morbidity in patients with DC, but from analyzing the
morbidity of some of the most influential studies, such as
the meta-analysis of Papi et al. [19] and Gurusamy and
Samraj [12], we note that there were no significant differences
between both groups. We have observed in our study that
the patients who benefit most from EC were those with a
Charlson index > 3 (greater age and comorbidity); concor-
dantly, the risk of complications is 50%higher in patientswith
Charlson index > 3 who underwent DC. This fact has also
been highlighted in recent studies [29–32].
We found no significant differences in morbidity among
DC patients who underwent surgery during the first 72
hours and those who underwent surgery after 72 hours
from the onset of symptoms. This result contrasts with the
work published by González-Rodŕıguez et al. [33], where the
morbidity was twice as high in surgery after 72 hours as in
surgery within the first 72 hours and with the publication of
Banz et al. [15], which notes higher rates of complications as
the time increases in the evolution of acute cholecystitis.
The risk of postoperative infection was twice as high in
the DC group as in the EC cases, which contrasts with the
results of the meta-analysis of Gurusamy and Samraj [12],
which notes a higher proportion of infections that required
percutaneous drainage in the EC group. With regard to
postoperative bleeding, we noted a lesser tendency towards
bleeding in DC than in EC, which concurs with the results
previously obtained by Norrby et al. [34]. We found that
the proportion of bile leakage and major injuries of the bile
duct was almost double in DC compared to that in EC, but
with no statistically significant differences, which is in line
with the results published by Gurusamy et al. in their various
meta-analyses [12, 14, 16]. In our experience, the laparoscopic
approach seems to be safer than the open surgery in the EC
group, but we must consider that the selection of the type
of surgery was not randomized in any case, so the results
are not conclusive. We must point out that we believe that
the ATOM [35] classification is the most appropriate form of
assessment of iatrogenic injury to the bile duct, but, given its
recent publication and the retrospective nature of the present
study, which does not permit us to know certain aspects for
the correct characterization of some of the injuries, we have
used the Strasberg classification.
In relation to the morbidity analysis, there is a factor that
has not been measured, which we believe may be of great
interest and, in some way, a crucial factor in supporting the
EC as the most optimal treatment for acute cholecystitis.
This factor is the assessment, within the DC group, of the
medical complications arising during the medical treatment
of cholecystitis, as well as the deterioration in health of
patients occurring between the index episode and the elective
cholecystectomy.
Despite the fact that the mortality rate was more than
twice as high in the DC group as in the EC group, the
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differences were not significant. The majority of the previous
studies present similar mortality rates for both groups, with
percentages close to 1% [15, 19] orwithout registeredmortality
[12, 14, 16].
EC patients had a significantly lower average hospital stay
than that of DC patients. All of the articles published to date
offer significantly lower results of hospital stay in the EC
group, with differences in days of stay ranging from 2 days
in the population study of Banz et al. [15] to 10 days in the
van der Linden and Sunzel [4] and Papi et al. [19] studies. In
addition, many of the works published hospital stay results
very close to those of our EC group; among others, Lai et al.
showed 7.6 days [7], Papi et al. 10.6 days [19], and Gurusamy
et al. 6.7 days [14]. The patients who underwent surgery after
72 hours from the onset of symptoms presented an average
stay significantly higher than the patients operated on within
the first 72 hours, similar to theDCgroup, something thatwas
pointed out previously by other studies [6–10, 36–38]; this
is explained by the greater average stay prior to the surgery
of the patients who underwent surgery after 72 hours of the
symptoms onset.
The difference between the percentages of readmissions
of the EC and the DC groups is due to the readmissions
of the DC group that occur between the first admission
for acute cholecystitis and the admission to perform the
cholecystectomy (18.2%), which is somewhat lower than the
results provided by Lahtinen et al. [39] and Lau et al. [40],
with percentages of readmission prior to surgery between
25% and 30%.
We found a greater tendency towards reoperations in the
EC group with respect to the DC group, which contrasts with
the data published byBanz et al. [15] in their population study,
where they highlight a greater proportion of reoperations in
DC (27.9%) than in EC (11.9%).
As illustrated in the present study, the worst results of
DC as compared to EC are due, in great measure, to the
cases operated on earlier than expected and the nonoperated
patients, something that is avoided with the EC protocols.
The average hospital stay and the percentage of patients
who required a readmission, as well as the percentage of
patients who were admitted to the ICU, were all significantly
higher in the DC group than in the EC group. All of these
factors contribute to ensuring that, with a high probability,
the direct costs of EC treatment are lower than those of DC,
something also pointed out by other recent studies [17, 41–
43].
Main Limitations of the Study. (1) It is retrospective study.
(2) Patients are treated in two different hospitals. That
could induce variability in the surgical management or
perioperative treatment. However, this variability would be
minimal, since both hospitals are of the highest standard and
both universities. (3) The study just analyzes two different
treatment protocols; it is not an “intention to treat analysis”
actually.
Conclusion. EC provides better morbidity results, as well as
a clear trend toward lower mortality and fewer injuries to
the main bile duct. No differences were found in the rate
of complications between patients who underwent surgery
within the first 72 hours of symptoms and the patients
operated on more than 72 hours after the initiation of
symptoms. In addition, EC could be of benefit for elderly
patients with high comorbidity and lead to a reduction in
direct costs due to fewer stays in ICU, fewer readmissions,
and fewer days of hospital stay. We would recommend DC
only in cases where acute pancreatitis, choledocholithiasis, or
cholangitis cannot be ruled out and those with unacceptable
anesthetic risk at the time of diagnosis.
Additional Points
This paper is based on the thesis realized by Miguel
Sánchez-Carrasco “Evaluation of Early Cholecystectomy ver-
sus Delayed Cholecystectomy in the Treatment of Acute
Cholecystitis,” Department of Surgical Sciences, University
of Cantabria, 2014.
Competing Interests
The authors declare that there is no conflict of interests
regarding the publication of this paper.
References
[1] J. H. Mulholland, E. H. Ellison, and S. R. Friesen, Delayed
Operative Management of Acute Cholecystitis. Current Surgical
Management, Saunders, Philadelphia, Pa, USA, 1957.
[2] E. H. Ellison, J. H.Miholland, and S. R. Friesen, Early Operation
for Acute Cholecystitis. Current Surgical Management, Saunders,
Philadelphia, Pa, USA, 1957.
[3] B. Pines and J. Rabinowitch, “Perforation of the gallbladder in
acute cholecystitis,” Annals of Surgery, vol. 140, article 170, 1959.
[4] W. van der Linden and H. Sunzel, “Early versus delayed
operation for acute cholecystitis. A controlled clinical trial,”The
American Journal of Surgery, vol. 120, no. 1, pp. 7–13, 1970.
[5] T. Kiviluoto, J. Sirén, P. Luukkonen, and E. Kivilaakso, “Ran-
domised trial of laparoscopic versus open cholecystectomy for
acute and gangrenous cholecystitis,” The Lancet, vol. 351, no.
9099, pp. 321–325, 1998.
[6] C.-M. Lo, C.-L. Liu, S.-T. Fan, E. C. S. Lai, and J. Wong,
“Prospective randomized study of early versus delayed laparo-
scopic cholecystectomy for acute cholecystitis,” Annals of
Surgery, vol. 227, no. 4, pp. 461–467, 1998.
[7] P. B. S. Lai, K. H. Kwong, K. L. Leung et al., “Randomized trial
of early versus delayed laparoscopic cholecystectomy for acute
cholecystitis,” British Journal of Surgery, vol. 85, no. 6, pp. 764–
767, 1998.
[8] C. F. Chandler, J. S. Lane, P. Ferguson, J. E.Thompson, and S.W.
Ashley, “Prospective evaluation of early versus delayed laparo-
scopic cholecystectomy for treatment of acute cholecystitis,”The
American Surgeon, vol. 66, no. 9, pp. 896–900, 2000.
[9] A. S. Serralta, J. L. Bueno, M. R. Planells, and D. R.
Rodero, “Prospective evaluation of emergency versus delayed
laparoscopic cholecystectomy for early cholecystitis,” Surgical
Laparoscopy, Endoscopy and Percutaneous Techniques, vol. 13,
no. 2, pp. 71–75, 2003.
[10] M. Johansson, A. Thune, A. Blomqvist, L. Nelvin, and L.
Lundell, “Management of acute cholecystitis in the laparoscopic
HPB Surgery 7
era: results of a prospective, randomized clinical trial,” Journal
of Gastrointestinal Surgery, vol. 7, no. 5, pp. 642–645, 2003.
[11] S. B. Kolla, S. Aggarwal, A. Kumar et al., “Early vs delayed
laparoscopic cholecystectomy for acute cholecystitis: a prospec-
tive randomized trial,” Surgical Endoscopy and Other Interven-
tional Techniques, vol. 18, no. 9, pp. 1323–1327, 2004.
[12] K. S. Gurusamy and K. Samraj, “Early versus delayed
laparoscopic cholecystectomy for acute cholecystitis (review),”
Cochrane Database of Systematic Reviews, no. 4, Article ID
CD005440, 2006.
[13] T. Siddiqui, A. MacDonald, P. S. Chong, and J. T. Jenkins,
“Early versus delayed laparoscopic cholecystectomy for acute
cholecystitis: a meta-analysis of randomized clinical trials,”The
American Journal of Surgery, vol. 195, no. 1, pp. 40–47, 2008.
[14] K. S. Gurusamy, K. Samraj, C. Gluud, E. Wilson, and B. R.
Davidson, “Meta-analysis of randomized controlled trials on
the safety and effectiveness of early versus delayed laparoscopic
cholecystectomy for acute cholecystitis,” British Journal of
Surgery, vol. 97, no. 2, pp. 141–150, 2010.
[15] V. Banz, T. Gsponer, D. Candinas, and U. Güller, “Population-
based analysis of 4113 patients with acute cholecystitis: defin-
ing the optimal time-point for laparoscopic cholecystectomy,”
Annals of Surgery, vol. 254, no. 6, pp. 964–970, 2011.
[16] K. S. Gurusamy, C. Davidson, C. Gluud, and B. R. Davidson,
“Early versus delayed laparoscopic cholecystectomy for people
with acute cholecystitis,” The Cochrane Database of Systematic
Reviews, no. 6, Article ID CD005440, 2013.
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